Seven-day triple rabeprazole-containing Helicobacter pylori eradication therapy on the Texas-Mexican border

被引：0
|
作者：
Cardenas, V
Opekun, AR
Campos, A
Guerrero, L
El-Zimaity, HMT
Chavez, A
Graham, DY
机构：
[1] Univ Texas, Sch Publ Hlth, El Paso, TX 79968 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Micheal E De Bakey VAMC, Houston, TX USA
来源：
HELICOBACTER | 2005年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：537 / 537
页数：1
相关论文
共 50 条
  • [41] Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer:: a multicentre, randomized, single-blind study
    Spinzi, GC
    Boni, F
    Bortoli, A
    Colombo, E
    Ballardini, G
    Venturelli, R
    Minoli, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (03) : 325 - 330
  • [42] Is the Conventional 7-Day Triple Therapy Sufficient for Eradication of Helicobacter pylori?
    Huh, Kyuchan
    Kim, Yong Seok
    Kim, Sun Moon
    Lee, Tae Hee
    Im, Euyi Hyeog
    Choi, Young Woo
    Kang, Young Woo
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A496 - A496
  • [43] 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease -: A pilot study
    Lüth, S
    Teyssen, S
    Kölbel, CB
    Singer, MV
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (04): : 279 - +
  • [44] Consistent Helicobacter pylori eradication rates with rabeprazole-based triple therapy across demographic subgroups
    Vakil, N
    Stanton, D
    Hahne, W
    Barth, J
    Kovacs, T
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S21 - S21
  • [45] Racial demographics do not affect efficacy of rabeprazole-based, triple therapy for Helicobacter pylori eradication
    Vakil, N
    Schwartz, H
    Perdomo, C
    Barth, J
    Sontag, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S17 - S17
  • [46] Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection
    Lee, Young Dal
    Kim, Sung Eun
    Park, Seun Ja
    Park, Moo In
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Song, Jiyun
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 76 (03): : 142 - 149
  • [47] Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
    Seven, Gulseren
    Cinar, Kubilay
    Yakut, Mustafa
    Idilman, Ramazan
    Ozden, Ali
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (06): : 582 - 586
  • [48] The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
    Zhang, Zinan
    Liu, Fen
    Ai, Feiyan
    Chen, Xiong
    Liu, Rui
    Zhang, Chao
    Fang, Ning
    Fu, Tian
    Wang, Xiaoyan
    Tang, Anliu
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naive Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
    Tai, Wei-Chen
    Yang, Shih-Cheng
    Yao, Chih-Chien
    Wu, Cheng-Kun
    Liu, An-Che
    Lee, Chen-Hsiang
    Kuo, Yuan-Hung
    Chuah, Seng-Kee
    Liang, Chih-Ming
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (05) : 1415 - 1427
  • [50] Seven-day therapy with esomeprazole, amoxicillin and levof loxacin is very effective for H.pylori eradication
    de Boer, W. A.
    Ouwehand, M. E.
    Vos, A. H.
    Gisbertz, I. A. M.
    Janssen, M. J. R.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A33 - A33
12345